Structurally designed shRNAs
Provided is an improved design of shRNA based on structural mimics of miR-451 precursors. These miR-451 shRNA mimics are channeled through a novel small RNA biogenesis pathway, require AGO2 catalysis and are processed by Drosha but are independent of DICER processing. This miRNA pathway feeds active elements only into Ago2 because of its unique catalytic activity. These data demonstrate that this newly identified small RNA biogenesis pathway can be exploited in vivo to produce active molecules.
1. A pre-miR-451 structural mimic consisting of a short hairpin RNA molecule (shRNA) comprising
(i) a first sequence of 21, 22 or 23 nucleotides fully complementary to a sequence in the coding region of a target gene,
(ii) a second sequence directly following the first sequence, wherein the second sequence is fully complementary to the sequence of the first 17 or 18 nucleotides counted from the 5′ end of the first sequence,
which structural mimic is DICER independent and requires AGO2 catalysis.
2. The pre-miR-451 structural mimic of claim 1 , wherein in the shRNA the last 3 nucleotides of the first sequence form a loop region in the short hairpin molecule.
3. The pre-miR-451 structural mimic of claim 1 , wherein in the shRNA the last 4 nucleotides of the first sequence form a loop region in the short hairpin molecule.
4. The pre-miR-451 structural mimic of claim 1 , wherein the shRNA has a 1, 2, or 3 nucleotide overhang at its 3′ end.
5. The pre-miR-451 structural mimic of claim 1 , wherein the shRNA has more than a 3 nucleotide overhang at its 3′ end.
6. The pre-miR-451 structural mimic of claim 1 , wherein the shRNA has a 1, 2, or 3 nucleotide overhang at its 5′ end.
7. The pre-miR-451 structural mimic of claim 1 , wherein the shRNA has more than a 3 nucleotide overhang at its 5 end.
8. The pre-miR-451 structural mimic of claim 1 , wherein the shRNA has no 3′ or 5′ overhang.
9. The pre-miR-451 structural mimic of claim 1 , wherein the shRNA consists of from 38 to 50 nucleotides.
10. An expression vector comprising a sequence encoding the pre-miR-451 structural mimic according to claim 1 operably linked to an RNA polymerase promoter.
11. A method of attenuating expression of a target gene in a mammalian cell, the method comprising introducing into the mammalian cell an expression vector comprising a sequence encoding a pre-miR-451 structural mimic which is DICER independent and requires AGO2 catalysis and which consists of a short hairpin RNA molecule (shRNA) operably linked to an RNA polymerase promoter, the shRNA comprising:
(i) a first sequence of 21, 22 or 23 nucleotides fully complementary to a sequence in the coding region of the target gene,
(ii) a second sequence directly following the first sequence, wherein the second sequence is fully complementary to the sequence of the first 17 or 18 nucleotides counted from the 5′ end of the first sequence,
wherein the shRNA molecule is expressed in the mammalian cell in an amount sufficient to attenuate expression of the target gene in a sequence specific manner, whereby expression of the target gene is inhibited.
12. The method of claim 11 , wherein in the shRNA the last 3 nucleotides of the first sequence form a loop region in the short hairpin molecule.
13. The method of claim 11 , wherein in the shRNA the last 4 nucleotides of the first sequence form a loop region in the short hairpin molecule.
14. The method of claim 11 , wherein the shRNA has a 1, 2, or 3 nucleotide overhang at its 3′ end.
15. The method of claim 11 , wherein the shRNA has more than a 3 nucleotide overhang at its 3′ end.
16. The method of claim 11 , wherein the shRNA has a 1, 2, or 3 nucleotide overhang at its 5′ end.
17. The method of claim 11 , wherein the shRNA has more than a 3 nucleotide overhang at its 5 end.
18. The method of claim 11 , wherein the shRNA has no 3′ or 5′ overhang.
19. The method of claim 11 , wherein the shRNA consists of from 38 to 50 nucleotides.
20. The method of claim 11 , wherein the expression vector comprises a sequence encoding the pre-miR-451 structural mimic operably linked to an RNA polymerase promoter.